US STOCKS-Wall Street slides as Alphabet revenue miss revives AI capex jitters

By Reuters News

By Stephen Culp and Shashwat Chauhan

- US stock prices retreated on Thursday, with investors reassessing big tech's massive AI spending spree as they digested high-profile earnings, crucial inflation data and the US Federal Reserve's policy decision.

All three major US stock indexes were in negative territory, with the Nasdaq dragged sharply lower by tech and tech-related megacaps in the wake of Alphabet's GOOGL.O disappointing quarterly results released late Wednesday.

In contrast, the smallcap Russell 2000 .RUT advanced 0.8%.

Semiconductor stocks .SOX were poised to snap their four-day winning streak, dropping 2.0% as investors sought to distinguish between companies that can fund their lofty AI ambitions from those that burn through cash and borrow funds to realize their ambitions.

Alphabet GOOGL.O was in the latter camp following its quarterly report released late Wednesday. The Google parent's revenue miss was compounded by its accelerated AI-related cash burn. Its shares slid 13.2%.

"A risk-off day like this, with small caps outperforming, is a good sign that thus far the market's interpretation of cracks in the AI story doesn't mean cracks in every corner of the market," said Ross Mayfield, investment strategy analyst at Baird in Louisville, Kentucky. "There's plenty of other places to go with your money outside of the AI trade that have pretty decent prospects."

https://www.reuters.com/graphics/MICROSOFT-RESULTS/gkvleeglxpb/chart.png

On Wednesday, Federal Reserve policymakers chose to hold US rates steady, acknowledging that while price pressures remain "elevated," the central bank will decide on its next move as it "accumulates more information."

A raft of economic data released on Thursday answered that call, with a first take on third-quarter GDP that showed the US economy grew at a faster-than-expected pace in the third quarter, while price growth continued to gain heat with a war-related oil supply crunch feeding into broader, systemic inflation.

The Dow Jones Industrial Average .DJI fell 315.36 points, or 0.59%, to 52,163.07, the S&P 500 .SPX lost 48.73 points, or 0.63%, to 7,695.25 and the Nasdaq Composite .IXIC lost 441.15 points, or 1.66%, to 26,108.35.

Among the 11 major sectors in the S&P 500, communication services .SPLRCL and tech .SPLRCT were down the most, while healthcare .SPXHC led the gainers.

Third-quarter earnings season has crossed the halfway point, with 253 of the companies in the S&P 500 having reported. Of those, 81% have beaten analyst expectations, according to the most recent LSEG data.

Analysts now expect aggregate third-quarter S&P 500 earnings growth of 31.0%, year-on-year, per LSEG.

Caterpillar CAT.N topped quarterly profit estimates but left its growth targets unchanged. The heavy equipment maker's shares tumbled 9.5%.

Eli Lilly LLY.N jumped 6.3% after the drugmaker lifted its revenue outlook on the strength of weight-loss drug sales.

Ford F.N gained 2.9% following the automaker's third-quarter revenue beat.

Merck MRK.N beat earnings expectations on the strength of its cancer drug Keytruda and its HPV vaccine Gardasil. The drugmaker's shares advanced 4.4%.

Software stocks were broadly weak. Fortinet FTNT.O and ServiceNow NOW.N dropped more than 20% each after their quarterly results.

Marvell Technology MRVL.O slumped 12.8% after media reports said the company was in advanced talks to buy data-center optics maker Lumentum Holdings LITE.O. Lumentum shares rose 2.0%.

Amazon's AMZN.O shares were off 3.9% ahead of its earnings report, expected after the closing bell.

Advancing issues outnumbered decliners by a 1.59-to-1 ratio on the NYSE. There were 113 new highs and 155 new lows on the NYSE.

On the Nasdaq, 2,416 stocks rose and 2,221 fell as advancing issues outnumbered decliners by a 1.09-to-1 ratio.

The S&P 500 posted 19 new 52-week highs and six new lows while the Nasdaq Composite recorded 81 new highs and 131 new lows.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.